Central hemodynamics for risk reduction strategies: Additive value over and above brachial blood pressure

Current Pharmaceutical Design

Volumn 21, Issue 6, 2015, Pages 730-736

  Rinaldi, Elisa R ^a,b   Yannoutsos, Alexandra ^a   Borghi, Claudio ^b   Safar, Michel E ^a   Blacher, Jacques ^a  

^a HÔTEL DIEU   (France)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anti hypertensive treatment; Aortic stiffness; Cardiovascular risk reduction; Central pulse pressure

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CORONARY ARTERY BLOOD FLOW; HEART LEFT VENTRICLE HYPERTROPHY; HEART OUTPUT; HEMODYNAMICS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; RISK REDUCTION; VASCULAR RESISTANCE; BLOOD PRESSURE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BRACHIAL ARTERY; HEMODYNAMICS; HUMANS; HYPERTENSION; PULSE WAVE ANALYSIS; RISK REDUCTION BEHAVIOR;

EID: 84925879940     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666141023164530     Document Type: Article

References (53)

1. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903-13.
2. Mancia G, De Backer G, Dominiczak A, et al. Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-87.
3. Turnbull F. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003; 362: 1527-35.
4. Andersson OK, Almgren T, Persson B, Samuelsson O, Hedner T, Wilhelmsen L. Survival in treated hypertension: follow up study after two decades. BMJ 1998; 317: 167-71.
5. Glynn RJ, L’Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39: 105-10.
6. Blacher J, Evans A, Arveiler D, et al. on behalf of the PRIME Study Group. Residual coronary risk in men aged 50-59 treated for hypertension and hyperlipidemia in the population. The PRIME study. J Hypertens 2004; 22: 415-23.
7. Blacher J, Evans A, Arveiler D, et al. Residual cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME Study. Journal of Human Hypertension 2010; 24: 19-26
8. Maciej Banach, Wilbert S. Aronow Blood Pressure J-Curve: Current Concepts. Curr Hypertens Rep (2012) 14: 556-66
9. Mitchell GF, Hwang SJ, Vasan RS, et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation 2010; 121: 505-11.
10. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study. Hypertension 2007; 50: 197-203.
11. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39: 735-8.
12. Asmar RG, London GM, O’Rourke ME, Safar ME. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol. Hypertension 2001; 38: 922-6.
13. Nichols WW, O'Rourke MF, Vlachopoulos C. McDonald's Blood Flow in Arteries: Theoretic, Experimental and Clinical Principles. 6th Edition. Edward Arnold, London, 2011
14. Pauca AL, O’Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38: 932-7
15. McEniery CM, Yasmin, Hall IR, Qasem A, Wilkinson IB, Cockcroft JR. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity the anglo-cardiff collaborative trial (ACCT). J Am Coll Cardiol 2005; 46: 1753-60
16. Wilkinson IB, Mohammad NH, Tyrrell S, et al. Heart rate dependency of pulse pressure amplification and arterial stiffness. Am J Hypertens 2002; 15: 24-30.
17. London GM, Guerin AP, Pannier BM, Marchais SJ, Metivier F. Body height as a determinant of carotid pulse contour in humans. J Hypertens Suppl 1992; 10: S93-5
18. Agabiti-Rosei E, Mancia G, O’Rourke MF, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document. Hypertension 2007; 50: 154-60.
19. Benetos A, Thomas F, Joly L, et al. Pulse pressure amplification a mechanical biomarker of cardiovascular risk J Am Coll Cardiol 2010; 55: 1032-7. doi: 10.1016/j.jacc.2009.09.061
20. Najjar SS, Scuteri A, Shetty V, et al. Pulse wave velocity is an independent predictor of the longitudinal increase in systolic blood pressure and of incident hypertension in the Baltimore Longitudinal Study of Aging. J Am Coll Cardiol 2008; 51: 1377-83.
21. Laurent S, Cockcroft J, Van Bortel L, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588-605
22. Mattace-Raso FU, van der Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113: 657-63
23. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 20: 103: 987-92.
24. Laurent Stéphane, Boutouyrie Pierre, Asmar Roland, Gautier Isabelle, Laloux Brigitte, Guize Louis, Ducimetiere Pierre and Benetos Athanase Aortic Stiffness Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Hypertensive Patients. Hypertension 2001; 37: 1236-41
25. Vlachopoulos Charalambos, Aznaouridis Konstantinos, Stefanadis Christodoulos, Prediction of Cardiovascular Events and All-Cause Mortality With Arterial StiffnessA Systematic Review and Meta-Analysis. J Am College Cardiol 2010; 55(13):
26. Ben Schlomo Y, Spears M, Boustred C, et al. Predictive value of pulse wave velocity for cardiovascular events in 15, 220 subjects: an individual participant meta-analysis on behalf of the PWV collaborative group. J Hypertens 2010; 28(suppl A)E446
27. Mansour AS, Yannoutsos A, Majahalme N, Agnoletti D, Safar ME, Ouerdane S, Blaher J Aortic stiffness and cardiovascuolar risk in type 2 diabetes. Hypertens 2013; 31: 1584-92. doi: 10.1097/HJH.0b013e3283613074.
28. Laurent S, Cockcroft JR, van Bortel LM, et al. Abridged version of the expert consensus document. Artery Res 2007; 1: 2-12.
29. De Luca N, Asmar RG, London GM, O’Rourke MF, Safar ME. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens 2004; 22: 1623-30
30. Shim CY, Park S, Choi D, et al. Sex differences in central hemodynamics and their relationship to left ventricular diastolic function. J AmCollCardiol 2011; 57(10): 1226-33. 10.1016/j.jacc.2010.09.067.
31. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large-artery remodeling. Circulation 1999; 100: 1387-93.
32. Wang KL, Cheng HM, Chuang SY, et al. Central or peripheral systolic or pulse pressure: which best relates to target organs and future mortality?. J Hypertens 2009; 27: 461-7.
33. Vlachopoulos C, Aznaouridis K, O’Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31: 1865-71
34. Mahmud A, Feely J. Antihypertensive drugs and arterial stiffness. Expert Rev Cardiovasc Ther 2003; 1: 65-78
35. Boutouyrie P, Lacolley P, Briet M, et al. Pharmacological modulation of arterial stiffness. Drugs 2011; 71: 1689-701.
36. Ong KT, Delerme S, Pannier B, et al. Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients. J Hypertens 2011; 29(6): 1034-42
37. Shahin Y, Khan JA, Chetter I. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a metaanalysis and meta-regression of randomised controlled trials. Atherosclerosis 2012; 221(1): 18-33.
38. Mackenzie IS, McEniery CM, Dhakam Z, Brown MJ, Cockcroft JR, Wilkinson IB. Comparison of the effects of antihypertensive agents on central blood pressure and arterial stiffness in isolated systolic hypertension. Hypertension 2009; 54(2): 409-13.
39. Tropeano AI, Boutouyrie P, Pannier B, et al. Brachial pressure independent reduction in carotid stiffness after long-term angiotensin converting enzyme inhibition in diabetic hypertensives. Hypertension 2006; 48: 80-6.
40. Mahmud A, Feely J. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension. J Hum Hypertens 2000; 14: 541-6.
41. Mahmud A. Reducing arterial stiffness and wave reflection: quest for the Holy Grail. Artery Research 2007; 1: 13-9.
42. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53
43. Dahlöf Björn, Devereux Richard B, Kjeldsen Sverre E, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359: 995-1003
44. Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366(9489): 895-906
45. Boutouyrie P, Achouba A, Trunet P, Laurent S. Amlodipinevalsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study. Hypertension 2010; 55: 1314-22
46. Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113(9): 1213-25.
47. London GM, Asmar RG, O'Rourke MF, Safar ME. REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43(1): 92-9.
48. Wilkinson IB, MacCallum H, Flint L, Cockcroft JR, Newby DE, Webb DJ. The influence of heart rate on augmentation index and central arterial pressure in humans. J Physiol 2000; 525: 263-70.
49. Dhakam Z, Yasmin, McEniery CM, Burton T, Brown MJ, Wilkinson IB. A comparison of atenolol and nebivolol in isolated systolic hypertension. J Hypertens 2008; 26: 351-6
50. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004; 17: 118-23.
51. Kampus P, Serg M, Kals J, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness. Hypertension 2011; 57: 1122-8.
52. Sharman JE, Marwick TH, Gilroy D, Otahal P, Abhayaratna WP, Stowasser M; BP GUIDE (value of central Blood Pressure for GUIDing managEment of hypertension) study investigators. Randomized Trial of Guiding Hypertension Management Using Central Aortic Blood Pressure Compared With Best-Practice Care: Principal Findings of the BP GUIDE Study. Hypertension 2013; 62(6): 1138-45
53. McEniery CM, Yasmin, McDonnell B, Munnery M, Wallace SM, Rowe CV, Cockcroft JR, Wilkinson IB. Central pressure: variability and impact of cardiovascu-lar risk factors: the Anglo-Cardiff Collaborative Trial II. Hypertension 2008; 51: 1476-82.